Head to Head Stocks: Heron Therapeutics, Inc. (NASDAQ:HRTX), Chesapeake Energy Corporation (NYSE:CHK)

Heron Therapeutics, Inc. (NASDAQ:HRTX)

Heron Therapeutics, Inc. (NASDAQ:HRTX) closed at $24.92 on the last trading session with an increase of 1.05%, whereas, it previously closed at $24.66. The company has a market capitalization of $1.95 Billion. The company traded shares of 801277 on the trading day while its three month average volume stands at 825.1 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) produced diluted EPS of -2.47. The EPS estimate for next year as estimated by analysts is at 0.44 while EPS for next quarter is estimated at -0.48. Earnings per Share growth for this year is reported at 33.1, while the analysts estimated the EPS growth for next year at 0.44% and Earnings growth for next 5 years stands at 12.1% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 6.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Heron Therapeutics, Inc. (NASDAQ:HRTX) is at 0 while the forward p/e is at 57.03. The P/S or Price to Sales ratio of Heron Therapeutics, Inc. (NASDAQ:HRTX) stands at 25.13 and Price to Book or P/B for the most recent quarter stands at 5.26. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Heron Therapeutics, Inc. (NASDAQ:HRTX) are reported at 4.4 and 4.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Heron Therapeutics, Inc. (NASDAQ:HRTX) stands at -44, -55 and -49.1 respectively

The trailing twelve month Revenue of Heron Therapeutics, Inc. (NASDAQ:HRTX) is reported at 77.5 Million with income of -178800000. The outstanding shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) are 78.14 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 0.31 in the last six months. The insider ownership for the shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) is ticked at 0.13%, the figure is plummeted -0.47% in the last six months.

Some other important financial aspects to be discussed here for Heron Therapeutics, Inc. (NASDAQ:HRTX) is the Mean Target Price estimated by the analysts which stands at 52.82. The 52 week high of Heron Therapeutics, Inc. (NASDAQ:HRTX) is placed at 42.90 and 52 week low is standing at 21.25.

Performance wise the shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) fell down -4.48% for the week, it also rise 3.45% for the monthly performance, while for the quarter it went up -4.48%. The shares decrease -15.04% for the half year and plummeted for the Year-To-Date performance. The shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) shrinked -18.16% for the yearly performance.

Chesapeake Energy Corporation (NYSE:CHK)

Chesapeake Energy Corporation (NYSE:CHK) closed at $3.17 on the last trading session with an decrease of -4.8%, whereas, it previously closed at $3.33. The company has a market capitalization of $4.87 Billion. The company traded shares of 74.85 Million on the trading day while its three month average volume stands at 45.96 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Chesapeake Energy Corporation (NYSE:CHK) produced diluted EPS of 0.81. The EPS estimate for next year as estimated by analysts is at 0.66 while EPS for next quarter is estimated at 0.13. Earnings per Share growth for this year is reported at -5, while the analysts estimated the EPS growth for next year at 0.66% and Earnings growth for next 5 years stands at 5.7% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 3.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Chesapeake Energy Corporation (NYSE:CHK) is at 3.9 while the forward p/e is at 4.83. The P/S or Price to Sales ratio of Chesapeake Energy Corporation (NYSE:CHK) stands at 0.48 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 2.46. The quick ratio and the current ratio of Chesapeake Energy Corporation (NYSE:CHK) are reported at 0.6 and 0.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Chesapeake Energy Corporation (NYSE:CHK) stands at 6.5, -44.5 and 18.1 respectively

The trailing twelve month Revenue of Chesapeake Energy Corporation (NYSE:CHK) is reported at 10.23 Billion with income of 775 Million. The outstanding shares of Chesapeake Energy Corporation (NYSE:CHK) are 1.54 Billion. The institutional Ownership of the shares of 64.4 stands at 0.80%, this figure is increased 99.34 in the last six months. The insider ownership for the shares of Chesapeake Energy Corporation (NYSE:CHK) is ticked at 1.4%, the figure is plummeted -5.93% in the last six months.

Some other important financial aspects to be discussed here for Chesapeake Energy Corporation (NYSE:CHK) is the Mean Target Price estimated by the analysts which stands at 3.08. The 52 week high of Chesapeake Energy Corporation (NYSE:CHK) is placed at 5.60 and 52 week low is standing at 1.71.

Performance wise the shares of Chesapeake Energy Corporation (NYSE:CHK) fell down -7.04% for the week, it also rise 2.26% for the monthly performance, while for the quarter it went down 16.54%. The shares decrease -31.24% for the half year and flew up for the Year-To-Date performance. The shares of Chesapeake Energy Corporation (NYSE:CHK) grew 0.63% for the yearly performance.